431 – 440 of 526
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
A porous silicon immunoassay platform for fluorometric determination of alpha-synuclein in human cerebrospinal fluid
(
- Contribution to journal › Article
-
Mark
The cerebrospinal fluid "Alzheimer profile": Easily said, but what does it mean?
(
- Contribution to journal › Article
-
Mark
Low Levels of Soluble NG2 in Cerebrospinal Fluid from Patients with Dementia with Lewy Bodies.
2014) In Journal of Alzheimer's Disease(
- Contribution to journal › Article
-
Mark
White matter hyperintensities as a confounder in diffusion tensor imaging analysis of elderly cohorts
2014) ISMRM-ESMRMB(
- Contribution to conference › Abstract
- 2013
-
Mark
Low CSF Levels of Both α-Synuclein and the α-Synuclein Cleaving Enzyme Neurosin in Patients with Synucleinopathy.
(
- Contribution to journal › Article
-
Mark
Evaluating Amyloid-beta Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Tau pathology and parietal white matter lesions have independent but synergistic effects on early development of Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Plasma tau levels in Alzheimer's disease
(
- Contribution to journal › Letter
-
Mark
Fluid biomarkers in Alzheimer's disease - current concepts
(
- Contribution to journal › Scientific review
-
Mark
NG2 cells, a new trail for Alzheimer's disease mechanisms?
(
- Contribution to journal › Article